Effectiveness of Electroconvulsive Therapy in Postpartum Psychosis: A Systematic Review

Orlando Herrera-Barrón1, Ximena Cors-Cepeda, Cynthia López-García

  • 1School of Medicine and Health Sciences at Tecnológico de Monterrey, Monterrey, N.L. Mexico.

The Journal of ECT
|May 27, 2026
PubMed

Postpartum psychosis is a severe psychiatric condition that emerges shortly after childbirth. Electroconvulsive therapy provides rapid symptom relief, particularly in severe and treatment-resistant cases. Despite evidence supporting its effectiveness, the use of electroconvulsive therapy in postpartum psychosis remains limited and unstandardized. This systematic review evaluates the clinical effectiveness of electroconvulsive therapy in treating postpartum psychosis. A comprehensive search of PubMed/MEDLINE, Cochrane, SciELO, SCOPUS, and Web of Science identified 255 studies, of which 7 met the inclusion criteria. Electroconvulsive therapy was used exclusively in severe cases that did not respond to pharmacological treatment, leading to symptom improvement in all cases, with most achieving complete remission. The total number of electroconvulsive therapy sessions ranged from 5 to 15, with symptom improvement observed after 1 to 6 sessions and remission after 5 to 11 sessions. Reported side effects, including memory loss, mild cognitive deficits, and pain, were transient. These findings highlight the effectiveness of electroconvulsive therapy as a rapid and safe intervention for postpartum psychosis, particularly when pharmacological treatments are insufficient. However, small sample sizes and variability in treatment protocols limit the generalizability of results. Further prospective studies are needed to establish standardized guidelines and consider electroconvulsive therapy as a first-line treatment for postpartum psychosis.

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...